Pharmaceutical manufacturers operate under the most stringent regulatory framework in industrial production — cGMP, 21 CFR Part 11, data integrity requirements, and evolving serialization mandates. While most pharma plants collect extensive process data from batch records, environmental monitoring systems, and laboratory instruments, the gap between raw data and audit-ready reporting remains a critical compliance risk. Manufacturing analytics for pharma bridges this gap by transforming validated data sources into cGMP-aligned dashboards, Part 11-compliant audit trails, and real-time batch visibility — without compromising data integrity or validation status.
Pharma-Ready Analytics for cGMP Compliance
iFactory delivers 21 CFR Part 11-compliant dashboards with electronic signatures, audit trails, and validated data connectors — purpose-built for pharmaceutical manufacturing. See it on your data in a 30-minute demo.
cGMP Compliance Pillars
Current Good Manufacturing Practice rests on four interdependent pillars that span quality systems, facilities, materials, and production controls. Each pillar must be supported by documented procedures, training records, and data that can withstand regulatory inspection. Manufacturing analytics strengthens every pillar by automating evidence collection, trend monitoring, and exception reporting.
21 CFR Part 11 — Audit Trail Timeline
FDA 21 CFR Part 11 requires that electronic records include secure, computer-generated, time-stamped audit trails that capture who performed an action, when, and what changed. The timeline below visualises a typical compliant audit trail across a batch lifecycle — from user login through electronic signature — showing how manufacturing analytics maintains data integrity at every step.
ALCOA+ Data Integrity Hexagon
The ALCOA+ framework defines the six attributes of data integrity that underpin cGMP compliance and regulatory acceptance of electronic records. The hexagon below maps current organisational compliance across each dimension, highlighting where manufacturing analytics automation strengthens the weakest links in the data integrity chain.
The filled polygon represents current data integrity compliance across your organisation. iFactory analytics automates ALCOA+ adherence by enforcing mandatory fields, electronic signatures, audit trails, and data validation at the point of entry.
cGMP Dashboards with Part 11 Audit Trails
See how iFactory delivers validated analytics with electronic signatures, time-stamped audit logs, and ALCOA+ data integrity — purpose-built for pharmaceutical manufacturing. A pharma analytics specialist will walk you through a compliant deployment in 30 minutes.
Deviation CAPA Cycle — Closed-Loop Quality
Every deviation in pharmaceutical manufacturing triggers a closed-loop corrective and preventive action (CAPA) process. The cycle below maps the four essential stages — from deviation identification through verification of effectiveness — showing how manufacturing analytics connects each phase with traceable data, automated escalation, and timeline tracking.
Batch Disposition Scoreboard
Batch disposition — the final release, quarantine, or rejection decision — is the most critical quality event in pharmaceutical manufacturing. The scoreboard below shows real-time batch status across your production pipeline, with hold time tracking that flags batches at risk of exceeding disposition timelines and triggering deviation investigations.
Batches with hold time exceeding 30 days trigger automatic escalation to Quality Management for investigation and CAPA initiation.
Environmental Monitoring Zone Grid
Cleanroom classification in pharmaceutical manufacturing follows four ISO grades — A, B, C, and D — each with defined limits for airborne particles, temperature, humidity, and pressure differential. The zone grid below shows current readings across a typical aseptic processing facility, with color-coded cells that signal when any parameter approaches its alert or action limit.
| Parameter | Grade A (ISO 5) | Grade B (ISO 5) | Grade C (ISO 7) | Grade D (ISO 8) |
|---|---|---|---|---|
| Particles ≥0.5µm | 12 / m³ | 1,240 / m³ | 48,200 / m³ | 286,000 / m³ |
| Temperature | 20.2°C | 20.8°C | 21.5°C | 22.1°C |
| Relative Humidity | 38% | 42% | 58% | 45% |
| Pressure Differential | +15 Pa | +12 Pa | +8 Pa | +2 Pa |
| Viable (CFU/m³) | <1 | 3 | 18 | 45 |
Colours indicate status relative to regulatory action limits: Within limit, Alert threshold approaching, Action limit exceeded. iFactory analytics provides real-time zone dashboards with automated alert escalation per 21 CFR 211.22.
Stability Study Gantt — Timepoint Tracking
Stability studies are a regulatory requirement for every marketed pharmaceutical product, requiring precise tracking of multiple batches across extended time horizons. The Gantt chart below maps stability study timepoints — from initial (T0) through long-term (24-month) testing — with colour-coded completion status that manufacturing analytics uses to ensure no timepoint is missed.
Manufacturing Analytics in Pharma — FAQ
What is manufacturing analytics for pharmaceutical plants?
Manufacturing analytics for pharmaceutical plants is a software platform that collects, visualises, and analyses production data from batch records, environmental monitoring systems, laboratory instruments, CMMS, and ERP — delivering cGMP-compliant dashboards and reports. Unlike general-purpose BI tools, pharma analytics platforms understand cGMP data integrity requirements (21 CFR Part 11, ALCOA+), validated system requirements, and regulatory audit readiness.
How does manufacturing analytics support 21 CFR Part 11 compliance?
Manufacturing analytics supports 21 CFR Part 11 compliance through secure user authentication with role-based access, computer-generated time-stamped audit trails, electronic signature capabilities with dual-authorisation workflows, validated data connectors that preserve source system integrity, and read-only dashboards that prevent data alteration. The platform is deployed on validated infrastructure with IQ/OQ/PQ documentation available for regulatory inspection.
What is ALCOA+ and why does it matter for pharma analytics?
ALCOA+ is an FDA and EMA framework defining data integrity attributes: Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available. For pharma analytics, every data point must be traceable to its origin (who, what, when), stored in its original form, and preserved in an unalterable audit trail. Manufacturing analytics platforms enforce ALCOA+ through mandatory fields, field-level validation, electronic signatures, and immutable audit logging.
Can analytics integrate with validated systems without breaking validation?
Yes. Manufacturing analytics platforms connect to validated systems via read-only data connectors — typically OPC-UA, REST APIs, or database views — that extract data without writing back to the source system. The analytics layer operates as a separate validated system with its own IQ/OQ/PQ. Data is transformed and presented in cGMP-compliant dashboards without modifying the validated state of underlying MES, SCADA, or LIMS systems.
Which pharma KPIs should be tracked first?
Start with batch release cycle time, first-pass yield (FPY), deviation rate per batch, CAPA closure time, environmental monitoring excursion frequency, and equipment qualification status. These six KPIs provide a balanced view of quality, compliance, and operational efficiency. As your analytics maturity grows, layer in OEE for packaging, laboratory turnaround time, and stability study completion rates for full visibility across the plant.
Navigate Pharma Compliance with Data
iFactory delivers cGMP-aligned analytics with Part 11 audit trails, ALCOA+ data integrity, and validated deployment — purpose-built for pharmaceutical manufacturing. See it on your data in a 30-minute demo.
